Loading
Latest filing published 02 Nov 2017 for MPX Bioceutical Corporation.
No signal scores available.
All filings by Jeremy Budd on record concern MPX Bioceutical Corporation. The record holds 2 filings, all for trades on 30 October 2017.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 2 November 2017, reports a transaction in MPX Bioceutical Corporation. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations